Monday July 16, 2018
Home India NCW Rejects F...

NCW Rejects Finding That “India Is world’s most dangerous country for women”

The Commission rejects the survey in question

0
//
15
NCW Rejects Finding That
NCW Rejects Finding That "India Is world’s most dangerous country for women". Pixabay
Republish
Reprint

The NCW today rejected the finding of a survey that India is the world’s most dangerous country for women, and said the countries that have been ranked after India have women who are not even allowed to speak in public.

The Thomson Reuters Foundation, after a survey of about 550 experts on women’s issues, has ranked India as the world’s most dangerous country for women, followed by war-torn Afghanistan and Syria, due to the high risk of sexual violence.

National Commission for Women Chairperson Rekha Sharma rejected the survey report, claiming that the sample size was small and could not be representative of the whole country.

“The Commission rejects the survey in question. For a nation as big as India, with a population of approximately 1.3 billion, the sample size of the survey is not representative of the country as a whole,” she said.

“Women are very aware in India of issues and there is no way that we could be ranked number one in such a survey. The countries that have been ranked after India have women who are not even allowed to speak in public,” Sharma said, without naming a specific country.

The poll was conducted online, by phone and in person between March 26 and May 4 with an even spread across Europe, Africa, the Americas, South East Asia, South Asia and the Pacific.

The poll was a repeat of a survey in 2011 in which Afghanistan, Democratic Republic of Congo, Pakistan, India, and Somalia were named as the most dangerous countries for women.

women sitting on bench
women sitting on bench. Pixabay

The survey asked respondents which five of the 193 UN member states they thought were most dangerous for women and which country was worst in terms of healthcare, economic resources, cultural or traditional practices, sexual violence and harassment, non-sexual violence and human trafficking.

Respondents also ranked India the most dangerous country for women in terms of human trafficking, including sex slavery and domestic servitude, and for customary practices such as forced marriage, stoning and female infanticide, the foundation said in a statement.

Also read: Women safety: Execution of laws more important than formation

There was no official response by the Ministry of Women and Child Development. (IANS)

Click here for reuse options!
Copyright 2018 NewsGram

Next Story

Cepheid to Establish Manufacturing Unit for TB Diagnostics in India

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment

0
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach. (IANS)

Expanding its footprint in India, US-based molecular diagnostics company Cepheid Inc on Thursday announced its plans to establish a manufacturing unit in the country to improve Tuberculosis (TB) diagnostics.

Cepheid’s GeneXpert MTB/RIF test is a closed-cartridge-based system that is easy to operate by minimally trained staff and gives results in approximately two hours, speeding the conventional backlog that used to exist in traditional diagnostic methods.

The new manufacturing unit would produce MTB/RIF test cartridges, contribute to the government’s “Make in India” initiative and thus bringing the company’s global expertise in TB diagnostics to India, the company said in a statement.

As part of the plan, Cepheid also unveiled its latest portable, easy-to-use TB-testing system — the GeneXpert Edge — which is expected to be available in India later this year, the company said.

The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.

“Cepheid recognises the need for technological advancement and is committed to contributing significantly to India’s goal of TB eradication,” said Peter Farrell, Executive Vice President, Worldwide Commercial Operations, Cepheid.

Cepheid's Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB)
Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB).

“We are hopeful that GeneXpert Edge will help eliminate delays in TB diagnostics by providing definitive results within hours and facilitating fast and easy last-mile delivery even in the remote villages of India,” he added.

India has nearly one-fourth of the global TB patients and an estimated 4.8 lakh lives are lost every year due to delayed diagnosis and inadequate treatment and there are above 2.5 million new cases of TB every year. The country aims to eradicate TB by 2025.

Approved by the World Health Organisation (WHO) in 2010, more than 1,200 Cepheid’s GeneXpert Systems have been installed in the last two years at various Revised National Tuberculosis Control Programme (RNTCP) sites in the country and more than 2.5 million cartridges were supplied last year at various centres of Central TB Division (CTD).

Also Read: Fruit Bats Identified As Source Of Nipah Virus Outbreak in Kerala

Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB) and rifampicin-resistance mutations, which are markers for MDR-TB strains in under two hours.

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment.

Xpert MTB/RIF tests also have excellent negative predictive value, which allows clinicians to manage TB-negative patients more effectively to prevent unnecessary and costly respiratory isolations. (IANS)